Clinical trial
A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA
NCT01865799 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA
- Lead sponsor
- Gilead Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 22, 2013
- Completion date
- January 22, 2018
- Enrollment
- 64,186 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pre-exposure prophylaxis for prevention of hiv infection